2026年6月3日 · 自动抓取 · 最新研究 · 1 分钟阅读

Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis

Blood Cancer Journal, Published online: 03 June 2026; doi:10.1038/s41408-026-01533-8Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer

Blood Cancer Journal, Published online: 03 June 2026; doi:10.1038/s41408-026-01533-8Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis

本文自动抓取自 Blood Cancer Journal，原文链接：Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis

原文发布日期：2026-06-03

Back to Blog

View All Posts »

Monoclonal gammopathy of clinical significance: a multisystem review

Blood Cancer Journal, Published online: 29 May 2026; doi:10.1038/s41408-026-01528-5Monoclonal gammopathy of clinical significance: a multisystem review

Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with <i>NRAS</i> mutations to FLT3 inhibitors

Leukemia, Published online: 02 June 2026; doi:10.1038/s41375-026-02982-7Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibi

<i>TP53</i> deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome

Leukemia, Published online: 01 June 2026; doi:10.1038/s41375-026-02991-6TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome

Genetic and Clinical Features in TP53-Mutated Patients With Myelodysplastic Neoplasms: A Retrospective Study Based on Next-Generation Sequencing Data.

The recent fifth edition of World Health Organization and International Consensus Classification in 2022 recognized TP53-mutated myelodysplastic neoplasms (MDS) as a distinct entity requiring multi-hi

Related Posts

Monoclonal gammopathy of clinical significance: a multisystem review

Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with <i>NRAS</i> mutations to FLT3 inhibitors

<i>TP53</i> deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome

Genetic and Clinical Features in TP53-Mutated Patients With Myelodysplastic Neoplasms: A Retrospective Study Based on Next-Generation Sequencing Data.